AstraZeneca moves finance chief Dunoyer to head Alexion AstraZeneca will move finance chief Marc Dunoyer to head newly acquired rare diseases business Alexion, using the $39 billion takeover as an opportunity to freshen … Business • 04 Jun 21
CMO explains new AstraZeneca vaccine guidance The Acting Chief Medical Officer explains the new Astra Zeneca vaccine guidance claire byrne live • 12 Apr 21
Germany advises drug makers to examine supply chain German drug makers have been asked by the government to examine their supply chains for any vulnerability that could cause shortages of essential drugs in … Business • 29 Aug 18
